Cardiac Rehabilitation and Additional Physical Training in Elderly Patients After Acute Coronary Syndrome
Evaluation of Cardiac Rehabilitation Functional and Physical Capacity, Health-related Quality of Life and Associations With Frailty in Older Patients After Ischemic Heart Disease and Interventional Treatment
1 other identifier
interventional
100
1 country
1
Brief Summary
The aim of this study is to evaluate functional and physical capacity, health-related quality of life and associations with frailty in older patients after ischemic heart disease and interventional treatment with an individualized physical training program in the second phase of cardiac rehabilitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 6, 2020
CompletedFirst Submitted
Initial submission to the registry
February 21, 2021
CompletedFirst Posted
Study publicly available on registry
February 24, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2022
CompletedMarch 4, 2021
March 1, 2021
2.8 years
February 21, 2021
March 2, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Frailty level by Edmonton frail scale score
Frailty measured by The Edmonton frail scale score - 0-3 - fit, 4-5 - vulnerable, 6-7 - mild frailty, 8-9 - moderate frailty,10-17 - severe frailty.
baseline
Change from baseline functional capacity by six minutes walking test (6MWT)
6MWT measured by meters
baseline, 3 weeks
Change from baseline cardiopulmonary exercise capacity by maximal load (maxWatt)
Maximal load measured with spiroergometry by maximal watts
baseline, 3 weeks
Change from baseline cardiopulmonary exercise capacity by maximal oxygen consumption (peakVO2)
PeakVO2 measured with spiroergometry by millilitres of oxygen per kilogram of body mass per minute
baseline, 3 weeks
Change from baseline quality of life by MacNew questionnaire
The MacNew Heart Disease HRQL questionnaire consists of 27 items which fall into three domains (a 13-item physical limitations domain scale, a 14-item emotional function domain scale, and a 13-item social function domain scale). There are 5 items that inquire about symptoms: angina/chest pain, shortness of breath, fatigue, dizziness, and aching legs. The time frame for the MacNew is the previous two weeks.
baseline, 3 weeks
Secondary Outcomes (2)
Change from baseline physical performance by Short Physical Performance Battery (SPPB)
baseline, 3 weeks
Change from baseline muscular strength by one repetition maximum test (1RM)
baseline, 3 weeks
Study Arms (3)
Control group
NO INTERVENTIONCardiac rehabilitation physical training program included: respiratory muscle training (7 days/week, for 15 minutes) and aerobic exercises on cycle ergometers (6 days/week, for 10-30 minutes, 30-50% watts or 30-50% HRmax).
Intervention group 1
EXPERIMENTALCombinated physical training program: Respiratory exercises, aerobic training will be the same as in the control group. Additional exercises: balance training and strength exercises with weights, elastic resistance rubbers.
Intervention group 2
EXPERIMENTALCombinated physical training program: Respiratory exercises, aerobic training will be the same as in the control group. Additional exercises: balance training with static and dynamic balance training device Biodex Balance System TM SD and strength exercises with HUR strength training machines.
Interventions
Additional exercise program with balance and resistance training three times per week. The balance training included exercises to improve static as well as dynamic balance ability, for 15-20 minutes. The resistance training included exercises with weights (0,5, 1 or 2 kg), elastic resistance rubbers, intensity 30-50% 1-RM, 10 repetitions with 3 sets and 3 minute rest between sets.
Additional exercise program with balance and resistance training three times per week. The balance training included exercises with static and dynamic balance training device Biodex Balance System TM SD, for 15-20 minutes. Exercises are performed with the following programs: Postural stability training, Limits of stability training, Weight shift training, Maze control training, Random control training, Percent weight-bearing training. The resistance training included exercises with HUR strength training machines, intensity 30-50% 1-RM, 10 repetitions with 3 sets and 3 minute rest between sets. Strength training was performed with the following exercises: Leg press, leg extension, leg abduction, leg adduction.
Eligibility Criteria
You may qualify if:
- Patients after acute coronary syndrome and percutaneous coronary intervention or coronary bypass surgery;
- Age 65 years and older;
- minute walk distance (6-MWD) ≥150 meters;
- Left ventricular ejection fraction ≥ 40%;
- Patient's agreement to participate in the study.
You may not qualify if:
- combined coronary artery bypass grafting and valve surgery;
- Cardiac devices;
- Diseases in the musculoskeletal system or other organs complicating physical activity and exercise training;
- Exercise-limiting comorbidities (primarily orthopedic and neurological conditions that would exclude individuals from participating in cardiac rehabilitation according to study protocol), cognitive or linguistic deficits.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
LUHS hospital Kaunas Clinics Rehabilitation hospital of Kulautuva
Kulautuva, Kaunas County, Lithuania
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Aurelija Beigienė, MD
Study Record Dates
First Submitted
February 21, 2021
First Posted
February 24, 2021
Study Start
January 6, 2020
Primary Completion
October 30, 2022
Study Completion
October 30, 2022
Last Updated
March 4, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share